Literature DB >> 4049602

Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.

J M Baumann, K Lauber, F X Lustenberger, M Wacker, E J Zingg.   

Abstract

The highest degree of urinary supersaturation with respect to calcium oxalate monohydrate (COM) and brushite at which secondary nucleation and growth of small amounts of COM and hydroxyapatite (HAP) are inhibited was determined by new and simple methods. There were 39 subjects who produced 24 h-urine collections (11 idiopathic stone formers (ISF), 12 patients suffering from primary hyperparathyroidism (HPT) and 16 healthy controls (HC). These subjects had a moderate calcium and low oxalate intake. The results obtained were compared with the state of urinary saturation and with urine chemistry. The measurements of crystallization conditions with respect to COM were repeated in 26 subjects (11 ISF, 5 HPT, 10 HC) after a dietary oxalate load. In 24 h-urines of HC diluted to 2.4 1/24 h the degree of supersaturation necessary to induce crystallization of COM and HAP was 2-5 times higher than the state of urinary saturation measured under the same test conditions. ISF showed a decreased pyrophosphate concentration and a decreased inhibitory activity to HAP crystallization in their 24 h-urine. The urinary inhibitory activity towards crystallization of HAP showed a positive correlation to urinary pyrophosphate concentration. In the 24 h-urine of HPT hypercalciuria and increased saturation with respect to brushite which reached values to induce HAP crystallization were found. After a dietary oxalate load urinary supersaturation with respect to COM reached values to induce COM crystallization in ISF and HPT but not in HC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049602     DOI: 10.1007/BF00261818

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  17 in total

1.  The role of inhibitors and other factors in the pathogenesis of recurrent calcium-containing renal stones.

Authors:  J M Baumann; S Bisaz; R Felix; H Fleisch; U Ganz; R G Russell
Journal:  Clin Sci Mol Med       Date:  1977-08

Review 2.  Physicochemical aspects of urolithiasis.

Authors:  B Finlayson
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

3.  Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.

Authors:  W G Robertson; M Peacock
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

4.  Activity products in stone-forming and non-stone-forming urine.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

5.  A method for the concentration and for the colorimetric determination of nanomoles of inorganic pyrophosphate.

Authors:  J K Heinonen; S H Honkasalo; E I Kukko
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

6.  The direct measurement of inhibitory capacity to crystal growth of calcium oxalate in undiluted urine and in other inhibitor containing solutions.

Authors:  J M Baumann; M Wacker
Journal:  Urol Res       Date:  1980

7.  The expectation of free and fixed particles in urinary stone disease.

Authors:  B Finlayson; F Reid
Journal:  Invest Urol       Date:  1978-05

8.  Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques.

Authors:  J M Baumann; M Wacker
Journal:  Urol Res       Date:  1979-09

9.  Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods.

Authors:  C Y Pak; Y Hayashi; B Finlayson; S Chu
Journal:  J Lab Clin Med       Date:  1977-04

10.  Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.

Authors:  P G Koutsoukos; M E Sheehan; G H Nancollas
Journal:  Invest Urol       Date:  1981-03
View more
  13 in total

1.  Investigations on macromolecular precipitation inhibitors of calcium oxalate.

Authors:  P Schnierle; F Sialm; H G Seiler; F Hering; G Rutishauser
Journal:  Urol Res       Date:  1992

Review 2.  Clinical investigations.

Authors:  F Hering
Journal:  Urol Res       Date:  1990

Review 3.  Physico-chemical aspects of calcium stone formation.

Authors:  J M Baumann
Journal:  Urol Res       Date:  1990

4.  Effects of urinary macromolecules on the crystallization of calcium oxalate.

Authors:  H G Tiselius; A M Fornander; M A Nilsson
Journal:  Urol Res       Date:  1990

5.  Automated and computer-controlled method for the measurement of the crystallization of calcium oxalate monohydrate in urine.

Authors:  D Tassile; B Affolter; J M Baumann; H P Siegrist; H J Keller
Journal:  Urol Res       Date:  1995

6.  In vitro crystallisation systems for the study of urinary stone formation.

Authors:  W Achilles
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.

Authors:  J M Baumann; D Ackermann; B Affolter
Journal:  Urol Res       Date:  1989

8.  Studies of urinary calcium oxalate crystallization in clinical research.

Authors:  J M Baumann
Journal:  Urol Res       Date:  1989

9.  How reliable are the measurements of crystallization conditions in urine?

Authors:  J M Baumann
Journal:  Urol Res       Date:  1988

10.  Chemical factors governing the state of saturation towards brushite and whewellite in urine of calcium stone formers.

Authors:  D Ackermann; J M Baumann
Journal:  Urol Res       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.